日期: 2026 年 2 月 6 日

HONG KONG, Feb 5, 2026 - (ACN Newswire via SeaPRwire.com) – Organised by the Hong Kong Trade Development Council (HKTDC), the world’s largest one-stop jewellery marketplace will return in early March under its proven “Two Shows, Two Venues” format. The 12th Hong Kong International Diamond, Gem & Pearl Show will take place from 2 to 6 March at AsiaWorld-Expo and will feature a wide range of jewellery raw materials. Also, the 42nd Hong Kong International Jewellery Show will be held from 4 to 8 March at the Hong Kong Convention and Exhibition Centre and will showcase finished jewellery pieces.Jenny Koo, Deputy Executive Director of the HKTDC, said: “This year’s twin jewellery shows bring together some 4,000 exhibitors from over 40 countries and regions, with 70% coming from outside Hong Kong. Exhibitor participation from Brazil, United Arab Emirates and India has expanded, and Uzbekistan joins for the first time. The HKTDC presents the world’s largest one-stop jewellery marketplace to highlight Hong Kong’s status as an international trade capital and jewellery sourcing hub.”In reviewing the global jewellery market, Hong Kong’s export volume of premium jewellery to ASEAN recorded a 51% increase, while exports to the United Kingdom, Australia and Switzerland grew year-on-year by 36%, 28% and 10% respectively.Over 40 themed pavilions, including a new Hard Pure Gold PavilionThe twin shows attract strong global industry support, with exhibitors participating from over 40 regional and industry pavilions. Participating regions include Chinese Mainland, Taiwan, India, Israel, Korea, Myanmar, Singapore, Sri Lanka, Thailand, Uzbekistan, Belgium, Germany, Italy, Spain, Türkiye, Brazil, Colombia, Mexico and the United States, etc.The World Gold Council debuts the Hard Pure Gold Pavilion, featuring a total of 11 exhibitors from Chinese Mainland, showcasing innovative gold craftsmanship to the global market. The pavilion aims to leverage the fairs as a springboard for international expansion.The Hong Kong Watch Manufacturers Association Ltd will participate as a pavilion for the first time, while the Zhushan Turquoise pavilion from Hubei will also make its debut. Other returning participants include the Tanzanite Foundation, the International Colored Gemstone Association (ICA), the Asia Pacific Creator Association, and the Asia Jewellery Culture Design and Crafts Association. The Hong Kong Jewellery & Jade Manufacturers Association will once again join forces with the Italian Exhibition Group (IEG) to present advanced jewellery manufacturing equipment and technologies.International brands in the spotlightThe Hall of Fame at the Hong Kong International Jewellery Show makes a highly anticipated return this year with more than 40% expansion in scale. It will welcome renowned international jewellery brands and help enhance global brand exposure. Turkish diamond jewellery brand Zen Diamond (Booth: CEC 3B-C12) presents diamond ring collections featuring exquisite cutting techniques. At the Hall of Extraordinary, Hong Kong exhibitor Continental Diamond Company (Booth: CEC GH-C07) showcases an 18K white and rose gold ring set with blue and light pink diamonds. Another Hong Kong exhibitor, Unique Brilliant Ltd (Booth: CEC GH-C13), unveils a necklace and earring set, the rubies display the coveted “pigeon blood red” colour.Oriental Aesthetics showcases cultural heritage craftsmanshipThis year’s shows will feature numerous jewellery pieces inspired by Asian culture and heritage. Chinese Mainland exhibitor, Guangdong JIABAO Pavilion Jewellery (Hong Kong) Company Ltd (Booth: CEC GH-A16) presents an 18K gold, handmade filigree butterfly brooch, made with national intangible heritage craft, with each piece taking over four months to complete. Another Chinese Mainland exhibitor, Shenzhen Meifei Precious Metals Co Ltd (Booth: CEC 3E-E02), brings a “Palatial Modern Chinese Style” jewellery series incorporating six traditional gold techniques, blending heritage craftsmanship with modern jewellery design.In recent years, hard pure gold technology has gained strong momentum in Chinese Mainland. Its high purity and enhanced hardness enable lighter, more durable designs with modern aesthetics. A seminar organised by the World Gold Council will examine the latest developments in the global gold market and hard pure gold technology.During the fairs, a series of events spotlighting Oriental aesthetics in jewellery will be staged. Hong Kong International Fashion Chuk Kam Jewellery Design Competition 2026, organised by the Jewellers’ and Goldsmiths’ Association of Hong Kong Limited, encourages designers to create commercially viable and culturally rich gold jewellery for young consumer markets in ASEAN and the Middle East. Its award presentation ceremony will be held during the fairs.In addition, the inaugural International Fei Cui Jewellery Design Competition 2026, organised by the Hong Kong Jade Association, will also host its awards presentation during the fairs.Creative design sets the trendInnovative and trend-driven products help the industry stand out. Austy Lee Company Ltd (Booth: CEC 1E-F32) introduces bangles inspired by zebra patterns for the Year of the Horse. Designer Galleria welcomes new exhibitor Zheng Hong Collective (Booth: CEC 1CON-067A), featuring a brooch whose movable wings and tail sway with the wearer.The 27th Hong Kong Jewellery Design Competition, themed “Pure Elegance – Natural Beauty”, returns to nurture creative talent. Local students and industry professionals interpret the beauty of nature and their design stories through their creations, highlighting the diverse facets of jewellery design. Winning designs will be announced during the fairs.Rare treasures dazzle across both showsAs always, the twin shows offer buyers an outstanding selection of antique and rare jewellery. At the Hong Kong International Jewellery Show, Hong Kong exhibitor Baroque Antique & Jewellery Limited (Booth: CEC CH-F13) presents a 1970s Buccellati pink sapphire suite, while World Coins Co., Ltd. (Booth: CEC CH-N12) showcases a 19th-century Italian bi-colour enamel diamond piece preserved in its original box for over 100 years. At the Hong Kong International Diamond, Gem & Pearl Show, German exhibitor Caram e.K. (Booth: AWE 8-F05) features an 18.98-carat AGL-certified natural pink sapphire, while Canadian exhibitor Korite Ammolite Ltd. (Booth: AWE 8-F35) displays an 18K gold AA-grade ammolite and diamond necklace.The Hong Kong International Jewellery Show will also host a seminar titled “The Origins of Style: Tracing the Imprint of Time and Craftsmanship.” This seminar will invite British historian and jewellery authority Dr. Jack Ogden to speak. He will provide an in-depth analysis of the evolution of jewellery craftsmanship and changes in aesthetic tastes across different eras.Over 20 forums on hot topics including AI and digital marketingMore than 20 seminars and networking sessions will be held, covering industry trends, digital marketing and jewellery technologies. A session will examine how artificial intelligence moves from design to commercialisation to drive the development of the jewellery industry. There will also be seminars where influencers share how to leverage e-commerce platforms to enhance jewellery brand visibility, boost sales, and share practical experience, to help the industry accelerate the integration and synergy between online and offline channels.Business opportunities and industry exchangeThe exhibition attracts major international jewellery retail chains, as well as high-end, affordable luxury, and designer jewellery brands from around the world for sourcing. It creates business opportunities for both buyers and sellers while fostering industry exchange.The HKTDC has partnered with the Hong Kong Tourism Board and local enterprises to provide exclusive buyer privileges. These offers include dining, air tickets, and hotels, enabling buyers to enjoy Hong Kong’s unique charm while attending the fairs. The HKTDC will arrange free shuttle bus services between AsiaWorld-Expo and urban areas (including the Hong Kong Convention and Exhibition Centre in Wan Chai). For details, please refer to the fair’s official website.Combining online and offline services to facilitate sourcingThe shows use the EXHIBITION+ hybrid format. In addition to on-site procurement, the HKTDC’s AI-powered “Click2Match” will provide online business-matching for exhibitors and buyers from 23 February to 13 March. On-site buyers can use "Scan2Match" to scan exhibitors’ QR codes and continue discussions with exhibitors online during or after the show. To ease the buyer admission process, the HKTDC Marketplace App and the official websites of the two shows provide online verification functions. Buyers need only register through these platforms and upload a photo and valid identification to obtain a verified eBadge for direct entry, greatly reducing queuing times for onsite registration and verification and enhancing sourcing efficiency.Photo download: https://bit.ly/4ayrcAoAttending the press conference to introduce the twin jewellery shows today (5 February): Jenny Koo, HKTDC Deputy Executive Director (centre), Winston Chow, Chairman, HKTDC Jewellery Advisory Committee (left) and Kent Wong, Chairman, HKTDC Hong Kong International Jewellery Show and HKTDC Hong Kong International Diamond, Gem and Pearl Show Fair Organising Committee (right)Jenny Koo (front row, third left) took a group photo with members of the organising committee of the HKTDC Hong Kong International Jewellery Show and the Hong Kong International Diamond, Gem and Pearl Show, joined by celebrity guestArtist Hera Chan (third right) led a group of models to exhibit exquisite jewellery pieces from the showsArtist Hera Chan wore a natural Myanmar jadeite set presented by exhibitor On Tung Company. The exquisite ensemble featured a translucent emerald green jadeite and diamond necklace, ring, and earrings, showcasing a regal and graceful designThe phoenix features in traditional Chinese wedding jewellery, symbolizes auspiciousness and good fortune. Exhibitor Lao Feng Xiang Jewellery Hong Kong Limited presented a "China chic" wedding collection imbued with Oriental charm, crafting accessories that embody the imperial elegance of a royal court for womenWebsites Hong Kong International Jewellery ShowExhibition websitehttp://hkjewelleryshow.hktdc.com/tcShuttle bus detailshttps://www.hktdc.com/event/hkjewellery/tc/travel-to-fairground-hkcecActivity listhttps://www.hktdc.com/event/hkjewellery/tc/intelligence-hub  Hong Kong International Diamond, Gem & Pearl ShowExhibition websitehttp://hkdgp.hktdc.com/tcShuttle bus detailshttps://www.hktdc.com/event/hkdgp/tc/travel-to-fairground-aweActivity listhttps://www.hktdc.com/event/hkdgp/tc/intelligence-hubHKTDC Media Room: https://mediaroom.hktdc.com/enMedia enquiriesPlease contact HKTDC’s Communication & Public Affairs Department:Winnie KanTel: (852) 2584 4055Email: winnie.wy.kan@hktdc.orgKaty WongTel: (852) 2584 4524Email: katy.ky.wong@hktdc.orgJane CheungTel: (852) 2584 4137Email: jane.mh.cheung@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Feb 5, 2026 - (ACN Newswire via SeaPRwire.com) – According to the disclosure of interests information released by the Hong Kong Stock Exchange, GIC Private Limited made its equity investment in Ascletis Pharma by acquiring 64,128,000shares at a price of HKD12.18per share, involving a total consideration of approximately HKD781.08million (equivalent to approximately USD100.01 million). Following the transaction, GIC's shareholding in Ascletis Pharma amounted to 64,128,000shares, representing a shareholding percentage of 6.42%, marking GIC's initial entry into the company's shareholder base. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Feb 6, 2026 - (ACN Newswire via SeaPRwire.com) – Everest Medicines today announced that China's National Medical Products Administration (NMPA) has approved VELSIPITY(R) (etrasimod arginine tablets) for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.UC is a chronic, relapsing, non-specific inflammatory bowel disease. In China, the incidence and prevalence of UC are accelerating, with a clear trend toward younger patients. The patient population is projected to increase from approximately 0.98 million in 2025 to 1.50 million by 2031.There remains a critical need for therapies that offer sustained and comprehensive disease control.As a next-generation selective S1P receptor modulator, VELSIPITY(R) offers the potential for rapid onset of action, and long-lasting clinical remission and mucosal healing through an oral, once-daily regimen for adult patients with moderately to severely active UC.The approval was based on results from the Asian multicenter Phase 3 ENLIGHT UC study (ES101002) and the global ELEVATE UC Phase 3 program (ELEVATE UC 52 and ELEVATE UC 12). The ENLIGHT UC study is the largest Phase 3 trial of moderately to severely active UC in Asia completed to date, with 340 eligible subjects randomized to treatment with VELSIPITY(R) or placebo. The study results showed that, VELSIPITY(R) demonstrated statistically significant and clinically meaningful improvements across all primary and secondary efficacy endpoints during both the 12-week induction period and the 40-week maintenance period. The safety profile of VELSIPITY(R) was consistent with previous studies, with no new safety signals observed. The study confirms the efficacy and safety of VELSIPITY(R) in this population, with results published in The Lancet Gastroenterology & Hepatology.From a clinical value perspective，VELSIPITY(R) is a once-daily oral therapy with rapid onset of action, strong mucosal healing efficacy, and a favorable safety profile. Prof. Chen Minhu, Academic Leader and Chief Expert of the Department of Gastroenterology at The First Affiliated Hospital of Sun Yat-sen University noted that UC is rapidly increasing in China and follows a relapsing course that significantly impairs quality of life and places a substantial burden on both patients and the healthcare system. Achieving mucosal healing is a widely recognized treatment goal in clinical guidelines, as it improves symptom control, reduces relapse risk, and supports long-term disease management.“UC treatment in China has long faced limited efficacy, high relapse rates, safety concerns, and inconvenient dosing. Despite available biologics and small-molecule therapies, unmet clinical needs persist,” said Prof. Wu Kaichun of the First Affiliated Hospital of AFMU, principal investigator of VELSIPITY(R)’s Asian clinical trial. “Its approval represents an important milestone and validation, providing patients with a novel treatment option and advancing UC management.”“Autoimmune diseases have long-term impacts on patients worldwide, with significant unmet clinical needs persisting both in China and globally,” said Mr. Yifang Wu, Chairman of the Board of Everest Medicines. “The approval of VELSIPITY(R) underscores the clinical value of innovative therapies for UC and reflects Everest Medicines’ sustained commitment to advancing drug development in line with international R&D standards. We look forward to expanding our global reach and providing patients with broader access to innovative treatment options.”“Its approval in China addresses a critical unmet medical need and introduces a novel oral therapy promoting deep mucosal healing,” said Mr. Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines. “We are committed to rapidly commercializing VELSIPITY(R) and working toward its inclusion in the National Reimbursement Drug List to further expand patient access and affordability, benefiting more patients across China.”The clinical value of VELSIPITY(R) has been recognized in leading international clinical guidelines. Following its inclusion in the American Gastroenterological Association (AGA) Clinical Practice Guideline in December 2024 as a first-line treatment for ulcerative colitis , VELSIPITY(R) was also included in the American College of Gastroenterology (ACG) Clinical Guideline Update in June 2025, with strong recommendations supporting its use for both induction and maintenance of remission in patients with moderately to severely active UC. In 2024, VELSIPITY(R) was included in the Catalogues of Guangdong Province on Drugs and Medical Devices from Hong Kong and Macao in Urgent Clinical Use in Nine Mainland Municipalities of the Guangdong-Hong Kong-Macao Greater Bay Area, making it available at designated hospitals across the region. The localized production project for VELSIPITY(R) was launched at the Jiashan manufacturing site in March 2025, supporting its future commercialization in China.The successful approval of VELSIPITY(R) further strengthens Everest Medicines’ product portfolio in the field of autoimmune diseases and also forms a critical part of the 2030 strategy of the Company. This strategy is built on a dual-engine model of business development partnerships and in-house R&D, aiming to generate predictable value through commercialization while building long-term growth momentum through sustained innovation, thereby supporting pipeline continuity and sustainable development.The Company has established a portfolio of three commercial products and continues to develop a fully integrated commercial platform covering the entire product lifecycle.The Company targets annual revenue exceeding RMB10 billion by 2028, and RMB15 billion by 2030 (including approximately RMB9 billion from the existing pipeline and approximately RMB6 billion from newly in-licensed assets). Revenue is expected to grow at a compound annual growth rate (CAGR) of over 50% from 2025 to 2030 and to remain above 15% thereafte.Over the same period, the number of commercial products is expected to exceed 20, including NEFECON(R), VELSIPITY(R), XERAVA(R), Lerodalcibep and MT1013.Industry observers widely expect VELSIPITY(R) to become Everest's next blockbuster product, with analysts projecting peak sales of up to RMB 5 billion. As VELSIPITY(R) realizes its commercial potential, Everest's revenue mix and growth trajectory are expected to strengthen further. Looking ahead, Everest Medicines will continue to focus on therapeutic areas with significant unmet clinical needs. Leveraging its established commercialization capabilities and in-house R&D, the company aims to accelerate the launch of innovative therapies with global competitiveness, drive sustainable growth, and create greater health value for patients and society.  Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年2月6日 - (亞太商訊 via SeaPRwire.com) - 雲頂新耀今日宣佈，中國國家藥品監督管理局（NMPA）已批准維適平(R)（精氨酸艾曲莫德片, VELSIPITY(R)）的新藥上市許可申請（NDA），用於治療對傳統治療或生物制劑應答不充分、失應答或不耐受的中度至重度活動性潰瘍性結腸炎成人患者。潰瘍性結腸炎是一種病因尚不明確、易復發的慢性腸道炎症性疾病。近年來，中國潰瘍性結腸炎發病率持續上升，並呈現年輕化趨勢，預計患者人數將由2025年的約98萬增長至2031年的約150萬。疾病對患者生活質量帶來長期負擔，臨床亟需實現更加穩定、持久的疾病控制。作為新一代高選擇性S1P受體調節劑，維適平(R)每日一次口服，可實現快速起效和強效深度黏膜愈合，並具有良好的安全性特征，具備最佳藥物（best-in-disease）潛質，為成人潰瘍性結腸炎患者提供新的一線治療選擇。據悉，維適平(R)此次獲批，是基於亞洲多中心III期注冊臨床ENLIGHT UC研究（ES101002）的結果和全球III期注冊研究ELEVATE UC（包括ELEVATE UC 52和ELEVATE UC 12研究）的結果。ENLIGHT UC研究是迄今完成的最大規模亞洲中重度活動性潰瘍性結腸炎患者的III期注冊臨床研究，總計納入340名患者。結果顯示，維適平(R)治療組在所有主要和次要療效終點上均達到統計學顯著性與臨床意義，且安全性良好。研究結果已發表於國際頂級學術期刊柳葉刀子刊《The Lancet Gastroenterology & Hepatology》。從臨床價值來看，維適平(R)憑借每日一次口服的治療方案，能夠快速起效並達到臨床緩解，同時還在黏膜愈合和組織學改善等方面療效顯著，同時安全性良好。對此，中華醫學會消化病學分會前任主任委員、炎症性腸病學組組長、中山大學附屬第一醫院消化內科學術帶頭人、首席專家陳旻湖教授指出，我國目前正處於潰瘍性結腸炎發病率和患病率快速上升階段，該疾病常反復發作，嚴重影響患者生活質量，對個人、家庭和醫療資源造成沉重負擔。實現黏膜愈合有助於更有效地控制症狀，降低復發風險，改善患者生活質量。黏膜愈合是國內外臨床指南公認的潰瘍性結腸炎治療目標，這不僅關系到疾病的長期症狀緩解，也與改善患者生活質量密切相關。維適平(R)亞太臨床試驗牽頭研究者、世界胃腸病組織執委兼司庫、亞太地區消化病學會副主席、中華醫學會消化病學分會第十、十一屆副主委、空軍軍醫大學西京消化病醫院吳開春教授指出，長期以來，我國潰瘍性結腸炎治療面臨傳統療法療效有限、給藥便捷性差以及不良反應多等諸多局限。已獲批的生物制劑和小分子治療也存在「療效天花板」及「失應答」等問題。維適平(R)通過調控淋巴細胞遷移，從源頭控制腸道炎症，並促進黏膜愈合。在多個臨床研究中維適平(R)展現出顯著療效，尤其在快速起效、實現無激素緩解及深度黏膜愈合方面具有明顯臨床優勢。此次獲批標志著維適平(R)從臨床研究到上市的完整驗證，為患者提供創新治療選擇，並推動中重度潰瘍性結腸炎管理進入新階段。雲頂新耀董事會主席吳以芳表示：「自身免疫性疾病在全球範圍內對患者造成長期而深遠的影響，在中國乃至全球範圍內，仍存在大量尚未滿足的臨床需求。維適平(R)的獲批不僅體現了創新療法在潰瘍性結腸炎治療中的臨床價值，也彰顯了公司堅持以國際研發標准推進創新藥物發展的長期戰略。我們期待通過持續拓展全球化佈局，讓更多患者受益於高質量、具有突破性的治療選擇。」雲頂新耀首席執行官羅永慶表示: 「此次維適平(R)在中國的獲批，填補了中重度潰瘍性結腸炎治療領域的重要空白，並為以深度黏膜愈合為目標的創新口服治療提供了新的選擇。公司將加快推進維適平(R)的商業化進程，並積極推動納入國家醫保目錄，持續提升創新療法在中國的可及性和可負擔性，讓更多患者受益。」值得一提的是，維適平(R)的臨床價值已獲得多項國際權威指南的充分認可，被先後納入2024年美國胃腸病協會（AGA）臨床實踐指南及2025年美國胃腸病學院（ACG）臨床指南，並獲強烈推薦。此前，該藥已於2024年和2025年被列入粵港澳大灣區內地9市臨床急需進口港澳藥品醫療器械目錄（文件中名稱為「伊曲莫德」）。目前，維適平(R)已在美國、歐盟以及中國大陸、中國香港、中國澳門、新加坡等多個國家和地區獲得新藥上市批准。2025年3月，雲頂新耀啟動維適平(R)嘉善工廠建設項目，為本地化生產及長期可及性提供有力支持。維適平(R)的成功獲批，進一步夯實了雲頂新耀在自身免疫疾病領域的產品佈局，也是公司2030年發展戰略的重要組成部分。該戰略以「BD合作 + 自主研發」雙輪驅動為核心，致力於通過商業化實現確定性價值，同時通過持續創新研發構建長期成長動能，推動管線的延續性與可持續發展。在商業化平台建設上，雲頂新耀已佈局三款商業化產品，並著力建立全渠道商業化體系及藥品全生命周期商業化能力。計劃到2028年實現收入規模超過100億元人民幣，而到2030年收入規模超過150億元人民幣（其中現有管線銷售收入約90億元人民幣而新引進管線銷售收入約60億元人民幣）；收入的年複合增長率預計在2025至2030年超過50%，2030年後保持超過15%。同時，商業化產品數量將提升至20款以上，包括耐賦康(R)、維適平(R)、依嘉(R)、樂瑞泊(R)（萊達西貝普）及MT1013等。業內普遍認為，維適平(R)有望成長為雲頂新耀又一重磅產品，其銷售峰值預計可達50億元人民幣。隨著維適平(R)商業化進程的持續推進，公司整體收入結構與成長曲線有望進一步優化。未來，雲頂新耀將繼續聚焦重大未滿足臨床需求，持續強化差異化創新管線，加速推進具有國際競爭力的創新療法落地，助力公司實現可持續成長，並為患者與社會創造更大的健康價值。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

The accolades underscore Malaysia’s leading mineral water brand’s international achievements in their consistent pursuit of quality, excellence and industry leadershipKUALA LUMPUR, Feb 6, 2026 - (ACN Newswire via SeaPRwire.com) - Spritzer Berhad (“Spritzer” or “the Company”), Malaysia’s leading natural mineral water brand started the year on a strong note with a repeat of the annual recognition by two prestigious platforms, the Putra Brand Awards 2025 and the Superior Taste Award 2025. These achievements, their 10th and 15th recognition for each award respectively, reinforce Spritzer’s continued efforts and commitment to excellence, innovation and uncompromising standards in delivering high-quality natural mineral water locally and internationally.Spritzer Wins the Gold at the Putra Brand Awards 2025Spritzer was awarded the Gold Award in the Beverage – Non-Alcoholic category at the Putra Brand Awards (PBA) 2025, marking its 10th impressive win in the category, further reaffirming its status as Malaysia’s most trusted natural mineral water brand. The Putra Brand Awards are uniquely consumer-driven, with winners selected solely by Malaysian consumers as the judge of brand excellence across 30 categories. As a genuine reflection of the brand’s enduring consumer affinity, market confidence and brand relevance, the accolade is particularly meaningful.Spritzer’s win as the only mineral water brand amidst other well-loved global beverage brands in Malaysia highlights Spritzer’s competitiveness and firm standing in the national beverage landscape. The award was proudly accepted by Dr. Chuah Chaw Teo, Research and Development (R&D) Director of Spritzer, on behalf of the Company.“Winning the Putra Brand Awards for the 10th year affirms our consistent efforts to keep improving over the years,” said Dr. Chuah. “Behind this recognition lies years of disciplined research and development (R&D), stringent quality control, and continuous improvement across our operations and customer touch points. Our priority has always been to safeguard the integrity of our natural mineral water while innovating responsibly to meet the evolving needs of consumers and businesses.”Photo 1 and 2: Spritzer celebrates its Gold Award in the Beverage - Non-alcoholic Category at The Putra Brand Awards 2025A Superior Triumph in Taste GloballySpritzer’s product excellence was further validated internationally at the Superior Taste Award 2025, a globally respected certification conferred by the International Taste Institute in Brussels, Belgium known for its rigorous, professional sensory evaluation of food and beverage products. In 2025, Spritzer Natural Mineral Water secured the prestigious 3-Star Superior Taste Award for the 10th year, a milestone that continues to build on Spritzer’s 15-year legacy of recognition by the International Taste Institute.This long-term acclaim reflects the brand’s unwavering dedicated to delivering natural mineral water of exceptional quality and taste. It reaffirms Spritzer’s strong product capabilities, from taste profile to mineral composition, and its commitment to upholding stringent international benchmarks, further cementing its dominance in Malaysia’s bottled water sector and boosting consumer assurance across local and global markets.Established in 2005, the International Taste Institute is known for its independent, blind tasting methodology, conducted by a panel of over 250 world-class chefs and sommeliers from more than 20 countries worldwide. Products are assessed against strict sensory criteria and only those achieving a score above 70% are certified with the Superior Taste Award, with distinctions awarded based on performance.Photo 2: Spritzer secured the prestigious 3-Star Superior Taste Award for the 10th year for Spritzer Natural Mineral WaterReinforcing Trust Across Markets and StakeholdersTogether, these two awards signify strong domestic consumer confidence and international endorsement of product quality. Backed by robust R&D processes, consistent quality management and a long-standing heritage rooted in nature, Spritzer continues to demonstrate reliability and leadership in the industry.Dr. Chuah concluded, “These speak to the trust that consumers place in us every day. Spritzer remains committed to protecting the purity of our source, strengthening our innovation pipeline, and continuing to deliver natural mineral water of the highest quality that Malaysians and global consumers can rely on.”Supported by its partners, customers, and dedicated team, the Company will continue to represent Malaysian quality on the global stage.For more high-resolution photos, please download them here.About SpritzerEstablished in 1989, Spritzer is a leading Malaysian bottled water brand, sourcing natural mineral water from a protected 430-acre rainforest in Taiping. Naturally filtered through underground rock layers for over 15 years, our water is enriched with essential minerals like Silica, known to support skin, bones, hair, and nails.Combining smart manufacturing with sustainable practices, Spritzer ensures every bottle meets the highest quality and safety standards. Our packaging is 100% recyclable and made from recycled materials, reflecting our commitment to environmental stewardship and a circular economy.Tested annually by SIRIM to be free from microplastics, Spritzer offers consumers trusted, natural hydration. Our diverse product range includes Natural Mineral Water, Original and Flavoured Sparkling Water, Distilled Water, and Fruit-Flavoured Beverages—crafted to suit every lifestyle and occasion.With a clear vision to become a fully circular brand by 2030, Spritzer leads the industry in innovation, quality, and sustainability.Spritzer — where nature, innovation, and sustainability come together in every bottle.For more information, visit www.spritzer.com.myFor media inquiries please contact:Imelia KyraAssociate Consultant, Narro CommunicationsE: imelia@narrocomms.comWinnie ChinHead of Public Relations, Spritzer BhdE: winniecgl@spritzer.com.my Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Feb 6, 2026 - (ACN Newswire via SeaPRwire.com) – Eternal Beauty Holdings Limited (“Eternal Beauty” or the “Group”) (Stock Code: 6883.HK), a pioneer in China’s beauty and fragrance industry, announced its first-ever collaboration with Lane Crawford, a premier luxury department store, to launch an exclusive boutique niche fragrance section at its Harbour City store in Tsim Sha Tsui. The collaboration aims to further advances the Group’s strategy focused on high-margin niche fragrance brands, strengthens its premium brand footprint through an elite retail network, and captures the growing profit opportunities in the niche fragrance for Chinese Mainland and Hong Kong markets.The zone brings together four international niche fragrance brands under the immersive concept of a "Luxury Niche Perfume Street" with European flair, featuring Atkinsons, Clive Christian, Memo Paris and SOLFÉRINO, each presented with its unique style and heritage. Clive Christian and SOLFÉRINO are making their debut in Hong Kong, offering a rare experience to local high-end consumers. By leveraging Lane Crawford’s premium retail network that reaches high-spending customers, the Group effectively enhances brand penetration in the Hong Kong market. This initiative successfully introduces the Group’s portfolio into a core upscale retail destination in Hong Kong, demonstrating the Group’s strengths in channel expansion and retail curation, while further solidifying its brand influence and long-term growth momentum in the niche fragrance portfolio.Brand Introduction:AtkinsonsThe 200-year-old British "Royal Fragrance House" reinvents the rebellion and elegance of 19th-century English gentlemen, transforming historical formulas into a modern, contemporary aura.Clive ChristianThe first exclusive collectors’ boutique in Hong Kong: Clive Christian is a luxury British perfume house that creates the world's finest perfumes. A legacy of British craftsmanship, unparalleled quality in concentration and complexity, unashamedly indulgent and luxurious presentation.Memo ParisMemo Paris is a Parisian fragrance house, see each fragrance as a travel note captured in scent. Preserve memory of a journey to unique destination. Memo Paris sketches a delicate, emotional map of the world: a universe where memories become scents.SOLFÉRINODebuting brilliantly in Hong Kong, SOLFÉRINO is born in Paris, France, the brand draws inspiration from the historic architecture of this City of Lights, showcases French elegance with exceptional craftsmanship and presenting Parisian audacity and creativity.Ms. Wendy Lau, Executive Director of Eternal Beauty and Chairman of the International Fragrance Association, said, “With over 40 years of industry experience, Eternal Beauty has cultivated sharp market vision, distinctive taste, and profound expertise. This enables the Group to accurately identify and introduce brands that align with market trends and carry strong profit potential into the Greater China market, which continues to demonstrate vigorous consumption upgrade momentum. We are thrilled to partner with Lane Crawford, an influential luxury department platform in Asia, to create this exclusive boutique niche fragrance section in Hong Kong’s core luxury shopping district, leveraging the Group’s strengths in niche fragrance brand management and retail channel development. This is not only an important step for the Group to deepen the niche fragrance market, but also a concrete manifestation of our niche fragrance brand expansion strategy. Moving forward, the Group will continue to explore collaborations with top-tier retail partners. By introducing more niche brands with high growth potential, it will strengthen its long-term growth momentum and enhance sustainable profitability in the fragrance market.”Hong Kong's fragrance market continues to benefit from the momentum of the emotional economy, demonstrating relatively resilient growth against the backdrop of a steady recovery in the overall retail sector. In December 2025, the value of total retail sales in Hong Kong increased by 6.6% YoY; according to market’s outlook reports, the total retail sales in Hong Kong are expected to grow by nearly 8% in 2026, reaching approximately HKD 410 billion, indicating a continued recovery in local consumer demand. Ms. Chole Lam, Executive Director and Chief Executive Officer of Eternal Beauty, said, “In recent years, experiential retail and emotional consumption have gradually emerged as new retail trends, with emotional value playing an increasingly significant role in consumer decision-making. The ability to establish emotional resonance with consumers is becoming an important direction for brand expansion and product innovation. Emerging consumption segments, represented by high-end and niche fragrances, are more being regarded as categories that carry emotional value and lifestyle propositions, highlighting their growth potential in the retail recovery process.”Eternal Beauty has established an omni sales channel network over 400 cities across Chinese Mainland, Hong Kong and Macau. The cooperation with Lane Crawford is an important part of the Group’s retail channel strategy, aiming to enhance the consumer experience and sales conversion by leveraging the prime location and high customer traffic of the premium department store.Photo CaptionEternal Beauty and Lane Crawford debut landmark niche fragrance zone, bringing together four international niche fragrance brands under the concept of a "Luxury Niche Perfume Street". The zone immersively showcasing four distinctive and heritage-rich brands: Atkinsons, Clive Christian, Memo Paris, and SOLFÉRINO.Please download more high-resolution photos via link:https://drive.google.com/drive/folders/1nzCNkjNqd9f5RDCub3vmLpoesN52MJbS?usp=sharingAbout Eternal Beauty Holdings LimitedEternal Beauty Holdings Limited is the largest perfume group (apart from brand-owner perfume groups) in China (including Hong Kong and Macau) in terms of retail sales in 2023. It primarily sells and distributes products procured from third-party brand licensors, and deploys market for these brand licensors, offering such services as brand management, and designing and implementing customized market entry and expansion plans for their brands. The Group boasts large and diversified brand portfolios that include not only perfumes, but also color cosmetics, skincare products, personal care products, eyewear and home fragrances. As at 30 September 2025, it conducted product distribution and market deployment for a total of 74 external brands, including Hermès, Van Cleef & Arpels, Chopard, Albion and Laura Mercier, with products in different pricing tiers and of versatile features that meet the differentiated demands of consumers in Chinese Mainland, Hong Kong and/or Macau. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年2月6日 - (亞太商訊 via SeaPRwire.com) - 中國香水產業領航者穎通控股有限公司（「穎通控股」或「集團」）（股份代號：6883.HK）宣佈與頂級奢侈品百貨連卡佛達成首度合作，於尖沙咀海運大廈連卡佛內設立首個小眾香水限定專區，進一步落實集團聚焦高毛利小眾香水品牌的發展策略，並透過頂級零售網絡深化高端品牌佈局，把握中國內地及香港高端香氛市場持續增長所帶來的盈利機遇。​專區雲集四大國際高端香氛品牌，以充滿歐洲風情的「高級小眾香水街」為概念，沉浸式呈現 Atkinsons、Clive Christian, Memo Paris 及 SOLFÉRINO 四個各具風格與傳承的品牌。Clive Christian 及 SOLFÉRINO 更是首度登陸香港，為本地高端消費者帶來獨家體驗，並藉助連卡佛覆蓋高消費客群的優質零售網絡，有效提升品牌在香港市場的滲透率，進一步將集團旗下品牌引入香港核心高端零售據點，展現集團在渠道拓展與零售策展方面的實力，鞏固於高端香氛市場的品牌影響力及長期增長動能。品牌介紹：Atkinsons擁有二百年歷史來自英國的「皇室御用香氛品牌」，重塑十九世紀英倫紳士的叛逆與優雅，將歷史配方化為現代摩登氣息。Clive Christian香港首間典藏級專櫃：源自英國倫敦的 Clive Christian 被譽為「世界最奢華的香水之一」，致敬英國皇室貴族經典與頂級奢華工藝傳承，彰顯無可比擬永恆優雅的底蘊。Memo Paris來自法國的 Memo Paris 以旅行與記憶為靈感，以香氣銘記旅途故事，繪製一幅詩情畫意的香氛情感地圖，將世界景致匯聚於瓶中。SOLFÉRINO首次於香港耀目登場的 SOLFÉRINO 誕生於法國巴黎，靈感源自這座光之城的歷史建築，以精湛工藝詮釋法式優雅，創作前衛而富創意的香氣。穎通控股執行董事及國際香氛協會主席劉頴賢女士表示：「憑藉四十餘年的行業經驗，穎通積累了敏銳視野、獨到品味與深厚專業知識，得以精準甄選契合市場趨勢且具備盈利潛力的品牌，並引入蘊藏巨大消費升級動能的大中華市場。我們很高興與亞洲具影響力的奢侈品百貨連卡佛攜手，在香港核心奢侈品商圈打造首個小眾香水專區，充分發揮穎通在高端香氛品牌運營與零售渠道佈局方面的專長。這不僅是集團深化小眾香水市場的重要一步，更是我們高端香氛品牌佈局策略的具體實踐。未來，集團將持續探索與頂級零售夥伴的合作機會，引入更多具高成長潛力的小眾品牌，進一步強化集團在高端香氛市場的長期增長動能與可持續盈利能力。」香港香氛市場持續受惠於情緒經濟帶動，在整體零售業穩步復甦的環境下，展現出相對強韌的增長勢頭。2025年12月，香港零售業總銷貨價值按年上升6.6%；而根據市場展望報告預測，2026年香港零售總額有望增長近8%，達到約4,100億港元，顯示本地消費需求正持續回暖。穎通控股執行董事兼首席執行官林荊女士表示：「近年，體驗式零售和情緒消費漸成為零售新潮流，情緒價值在消費決策中的比重明顯提升，能否與消費者建立情緒共鳴，正日益成為品牌拓展與產品創新的重要方向。以高端與小眾香氛為代表的新興消費板塊，愈來愈多地被視為承載情緒價值與生活方式主張的品類，顯示其在零售復蘇進程中的增長潛力。」穎通控股已建立覆蓋中國內地、香港及澳門逾400個城市的全渠道銷售網絡，是次與連卡佛的合作為集團零售渠道升級策略的重要一環，旨在透過高端百貨的黃金地段與客流量，提升品牌消費體驗與銷售轉化。圖片說明穎通控股與連卡佛合作開設首個小眾香水專區，雲集四大國際高端香氛品牌，以充滿歐洲風情的「高級小眾香水街」為概念，沉浸式呈現 Atkinsons、Clive Christian, Memo Paris 及 SOLFÉRINO 四個各具風格與傳承的品牌。請通過此鏈接下載更多高清圖片：https://drive.google.com/drive/folders/1nzCNkjNqd9f5RDCub3vmLpoesN52MJbS?usp=sharing關於穎通控股有限公司穎通控股有限公司是中國（包括香港及澳門）最大的香水集團（除品牌所有者香水集團外，按2023年零售額計），主要從事銷售及分銷從第三方品牌授權商採購的產品及為該等品牌授權商進行市場部署，例如為其品牌設計及實施定制的市場進入及擴張計劃。穎通控股擁有龐大且多元化的品牌組合，不僅包括香水，還包括彩妝、護膚品、個人護理產品、眼鏡及家居香氛。截至2025年9月30日，穎通控股為合共74個外部品牌進行產品分銷及市場部署，包括 Hermès、Van Cleef & Arpels、Chopard、Albion及Laura Mercier，涵蓋多元化的定價層次及功能，迎合中國內地、香港及或澳門消費者的差異化需求。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年2月6日 - (亞太商訊 via SeaPRwire.com) - 2月4日至5日，中國再保召開2026年黨建和經營管理工作會議。會議以習近平新時代中國特色社會主義思想為指導，深入學習貫徹黨的二十大和二十屆歷次全會、中央經濟工作會議、中央金融工作會議、二十屆中央紀委五次全會精神，落實上級單位和監管部門管理要求，總結2025年工作，回顧「十四五」發展成效，深入分析當前形勢和任務，部署2026年重點工作。中國再保黨委書記、董事長莊乾志出席會議並講話，黨委副書記、副董事長、擬任總裁朱曉雲作經營管理工作報告，紀委書記李丙泉作紀檢工作報告，黨委副書記朱海林主持會議並作總結講話。財政部、國家金融監管總局、中投公司代表到會指導。高質量發展再上新台階會議指出，2025年，中國再保堅持以黨的政治建設為統領，全面加強黨的作風建設，深入貫徹中央八項規定精神學習教育取得實效。堅持金融工作的政治性、人民性，服務國家戰略風險保額超87.5萬億元，同比增長11.4%。聚焦主責主業持續深化改革創新，圓滿完成中再巨災公司增資，經營質效顯著提升，被認定為我國境內首家「國際活躍保險集團」。會議指出，「十四五」以來，中國再保以黨建「領航工程」聚力鑄魂，「世界一流」戰略願景振奮人心，經營理念重塑成效顯著，「一體兩翼」格局拓寬空間，數字化轉型穩步推進，國際化發展實現突破，承保利潤大幅改善，所有國際業務平臺均實現承保盈利，國際業務經營業績向穩向優，為「十五五」新征程打下良好基礎。譜寫「十五五」發展嶄新篇章會議指出，未來十年是我國保險業補缺口、實現高質量發展的關鍵時期。中國再保要以黨的政治建設為統領，緊扣金融工作主線，發揮保險再保險經濟「減震器」和社會「穩定器」功能，加快推進業務模式轉型和管理機制優化，加快提升專業能力，做到「五個堅持」和「五個突破」，在建設金融強國的偉大事業中堅定扛起中國再保的光榮使命。做到「五個堅持」，一是堅持2035年建成「世界一流」不動搖，錨定願景目標不放鬆。二是堅持穩中求進工作總基調，整體工作穩字當頭，具體工作以進促穩。三是堅持正確的經營觀、業績觀、風險觀，長期堅持「發展有規模、承保增效益、投資要穩健」的經營理念。四是堅持聚焦主責主業和發揮功能作用，積極主動融入中國金融改革發展大局。五是堅持高質量發展和高水平安全的有機統一，守牢風險防控底線。實現「五個突破」，一是業務轉型突破，攻堅克難，謀劃好再保險轉型發展路線圖、直接保險高質量發展路線圖、保險科技創新發展路線圖。二是治理結構突破，強化集團管控，完善治理機制，做到既「放得活」，又「管得好」。三是激勵約束突破，將「要我突破」轉變為「我要突破」，實現激勵有效、約束有力。四是國際化能力突破，打造國際化專業人才隊伍及境外機構管理團隊。五是企業文化塑造突破，追求專業盡責卓越工作目標，弘揚簡單、高效、務實、合規工作作風。會議強調，「十五五」期間，中國再保要堅持和加強黨的全面領導，以高質量黨建引領高質量發展；要志在一流，以自身高質量發展的確定性應對外部環境的不確定性；要增強大局觀念，自覺把工作融入黨和國家事業大局、世界一流建設新征程中謀劃推進；要勇於擔當，做行動派、實幹家，既真幹又會幹，用扎實奮鬥創造經得起實踐和歷史檢驗的工作業績。部署2026年重點工作會議明確，2026年，中國再保要堅持以習近平新時代中國特色社會主義思想為指導，深入貫徹黨中央決策部署，堅持用改革精神和嚴的標準管黨治企，擔當作為、攻堅克難，重點做好七方面工作。一是始終將黨的政治建設擺在首位，樹立正確的政績觀，扎實做好金融「五篇大文章」，提升各級幹部政治能力。二是深入貫徹新時代黨的組織路線，為集團高質量發展提供強有力幹部人才支撐。三是扎實開展「黨建效能提升年」，實現「兩個功能」融入中心工作的效能明顯提升。四是高質量編制「十五五」規劃，做好戰略任務分解落地。五是全面深化改革創新，增強高質量發展動能，強化集團管控引領，調動子公司經營管理主動性、積極性，進一步提升國際化、數字化發展水平。六是認真貫徹落實自我革命「五個進一步到位」重要要求，以更高標準更實舉措推進全面從嚴治黨。七是積極建設中再特色企業文化，為世界一流建設凝聚發展合力。會議要求，2026年集團系統經營管理工作要堅決貫徹「發展有規模、承保增效益、投資要穩健」的經營理念，以改革求突破、以轉型促發展、以創新增動能、以管理提質效，守穩築牢風險防線，不斷增強經營發展韌性，奮力實現「十五五」良好開局，譜寫高質量發展新篇章。同時，會議對各子公司經營要求進行具體部署。集團系統要堅持再保特色優勢，著力服務國家戰略；堅持總部統籌引領，著力強化穿透管理；堅持業務驅動導向，著力加快數字化轉型；堅持境外管控優化，著力提升國際競爭力；堅持築牢底線思維，著力強化全面風險管理。會議強調，中國再保要以更高標準、更實舉措推進全面從嚴治黨，把深入落實「從嚴監督執紀要進一步到位」作為貫穿全年的主題主線，強化政治監督，深化正風肅紀，一體推進不敢腐、不能腐、不想腐，持續開展「紀檢工作規範化法治化正規化建設年」行動，推進新時代新征程紀檢工作高質量發展，為集團公司「十五五」開好局起好步提供堅強保障。集團公司黨委、董事會、總裁室成員，各子公司班子成員、分/子公司及部門主要負責人，海外經營機構負責人，集團公司部門和處室負責人，老幹部代表等現場參會。集團系統其他相關人員通過視頻方式參會。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com